Clinical trial
Mineralocorticoid Receptor in the Treatment of Severe Depression
NCT00295347 · Universitätsklinikum Hamburg-Eppendorf, Other · Completed
Key facts
| NCT number | NCT00295347 |
|---|---|
| Title | Mineralocorticoid Receptor in the Treatment of Severe Depression |
| Official title | Mineralocorticoid Receptor in the Treatment of Severe Depression: A Randomized, Double Blind, and Placebo Controlled Trial |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Spironolactone, fludrocortisone, escitalopram |
| Enrollment | 65 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 23, 2006 |
| Last update posted | May 30, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: